Tsuneo Saga - Search Results

Year	Number of Results
2002	8
2003	7
2004	9
2005	8
2006	6
2007	16
2008	9
2009	9
2010	17
2011	22
2012	19
2013	26
2014	12
2015	25
2016	13
2017	11
2018	6
2019	7
2020	9
2021	7
2022	6
2023	5
2024	1

1

Thin-slice reverse encoding distortion correction DWI facilitates visualization of non-functioning pituitary neuroendocrine tumor (PitNET)/pituitary adenoma and surrounding normal structures.

Ito S, Okuchi S, Fushimi Y, Otani S, Wicaksono KP, Sakata A, Miyake KK, Numamoto H, Nakajima S, Tagawa H, Tanji M, Sano N, Kondo H, Imai R, Saga T, Fujimoto K, Arakawa Y, Nakamoto Y. Ito S, et al. Among authors: saga t. Eur Radiol Exp. 2024 Mar 7;8(1):28. doi: 10.1186/s41747-024-00430-8. Eur Radiol Exp. 2024. PMID: 38448783 Free PMC article.

2

Evaluating Reproducibility of the ADC and Distortion in Diffusion-weighted Imaging (DWI) with Reverse Encoding Distortion Correction (RDC).

Numamoto H, Fujimoto K, Miyake KK, Fushimi Y, Okuchi S, Imai R, Kondo H, Saga T, Nakamoto Y. Numamoto H, et al. Among authors: saga t. Magn Reson Med Sci. 2023 Nov 10. doi: 10.2463/mrms.mp.2023-0102. Online ahead of print. Magn Reson Med Sci. 2023. PMID: 37952942 Free article.

3

Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma.

Otani T, Miyake KK, Ishimori T, Kido A, Saga T, Nakamoto Y. Otani T, et al. Among authors: saga t. Asia Ocean J Nucl Med Biol. 2023;11(2):101-110. doi: 10.22038/AOJNMB.2023.69159.1481. Asia Ocean J Nucl Med Biol. 2023. PMID: 37324226 Free PMC article.

4

Denoising approach with deep learning-based reconstruction for neuromelanin-sensitive MRI: image quality and diagnostic performance.

Oshima S, Fushimi Y, Miyake KK, Nakajima S, Sakata A, Okuchi S, Hinoda T, Otani S, Numamoto H, Fujimoto K, Shima A, Nambu M, Sawamoto N, Takahashi R, Ueno K, Saga T, Nakamoto Y. Oshima S, et al. Among authors: saga t. Jpn J Radiol. 2023 Nov;41(11):1216-1225. doi: 10.1007/s11604-023-01452-9. Epub 2023 May 31. Jpn J Radiol. 2023. PMID: 37256470 Free PMC article.

5

FDG-PET findings associated with various medical procedures and treatments.

Okuyama C, Higashi T, Ishizu K, Saga T. Okuyama C, et al. Among authors: saga t. Jpn J Radiol. 2023 May;41(5):459-476. doi: 10.1007/s11604-022-01376-w. Epub 2022 Dec 28. Jpn J Radiol. 2023. PMID: 36575286 Free PMC article. Review.

6

Super-resolution application of generative adversarial network on brain time-of-flight MR angiography: image quality and diagnostic utility evaluation.

Wicaksono KP, Fujimoto K, Fushimi Y, Sakata A, Okuchi S, Hinoda T, Nakajima S, Yamao Y, Yoshida K, Miyake KK, Numamoto H, Saga T, Nakamoto Y. Wicaksono KP, et al. Among authors: saga t. Eur Radiol. 2023 Feb;33(2):936-946. doi: 10.1007/s00330-022-09103-9. Epub 2022 Aug 25. Eur Radiol. 2023. PMID: 36006430

7

Diagnostic advantage of thin slice 2D MRI and multiplanar reconstruction of the knee joint using deep learning based denoising approach.

Kakigi T, Sakamoto R, Tagawa H, Kuriyama S, Goto Y, Nambu M, Sagawa H, Numamoto H, Miyake KK, Saga T, Matsuda S, Nakamoto Y. Kakigi T, et al. Among authors: saga t. Sci Rep. 2022 Jun 20;12(1):10362. doi: 10.1038/s41598-022-14190-1. Sci Rep. 2022. PMID: 35725760 Free PMC article.

8

Correction to: Detection efficacy of PET/CT with ¹⁸F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.

Otani T, Saga T, Ishimori T, Kidera E, Shimizu Y, Aizawa R, Nakamura K, Goto T, Akamatsu S, Mizowaki T, Nakamoto Y. Otani T, et al. Among authors: saga t. Ann Nucl Med. 2022 May;36(5):504-505. doi: 10.1007/s12149-022-01736-6. Ann Nucl Med. 2022. PMID: 35298780 No abstract available.

9

Detection efficacy of PET/CT with ¹⁸F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.

Otani T, Saga T, Ishimori T, Kidera E, Shimizu Y, Aizawa R, Nakamura K, Goto T, Akamatsu S, Mizowaki T, Nakamoto Y. Otani T, et al. Among authors: saga t. Ann Nucl Med. 2022 Mar;36(3):302-309. doi: 10.1007/s12149-021-01704-6. Epub 2022 Jan 22. Ann Nucl Med. 2022. PMID: 35064537

10

Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo.

Shimizu Y, Koyasu S, Suzukida M, Izumi K, Kidera E, Shindo T, Saga T, Ono M, Takaori-Kondo A, Nakamoto Y. Shimizu Y, et al. Among authors: saga t. Ann Nucl Med. 2022 Mar;36(3):319-326. doi: 10.1007/s12149-021-01706-4. Epub 2022 Jan 16. Ann Nucl Med. 2022. PMID: 35034259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

222 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Results by year